Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Deutsche Boerse AG  >  3SBio Inc. (ADR)    YFK

No quotes available
-- EUR   0.00%
07/08 3SBIO : gets nod for colorectal cancer drug clinical trial
06/03 3SBIO INC. : (01530) says ITP drug get clinical trial approval
05/20 3SBIO INC. : (01530) withdraws breast cancer drug application
SummaryQuotesNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Engages in research, development, manufacturing and marketing of biopharmaceutical products

3SBio, Inc. operates as in investment holding company which engages in the development, production, marketing, and sale of biopharmaceutical products.

It is used in the field of medicine particularly in nephrology, oncology, supportive cancer care, inflammation and infectious diseases.

The company was founded by Jing Lou and Dan Lou in 1993 and is headquartered in Shenyang, China.
Managers
NameAgeSinceTitle
Jing Lou MD, PhD531993Chairman, President & Chief Executive Officer
Wei hong Xiao-2016Chief Operating Officer
Bo Tan, MBA432009Chief Financial Officer & Executive Director
Dong Mei Su, PhD452012Executive Director
Bin Huang, MBA551993Executive Director & Vice President
Dong Liu, MBA432014Non-Executive Director
Dong LV, PhD412014Non-Executive Director
Tian Ruo Pu, MBA472014Independent Non-Executive Director
David R. Parkinson MD, PhD652014Independent Non-Executive Director
Jun Ma, PhD532014Independent Non-Executive Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 2,532,313,570 986,372,150 39.0% 0 0.0% 39.0%
Shareholders
NameEquities%
CITIC Private Equity Funds Management Co., Ltd. 712,258,360 28.1%
Jing Lou, MD, PhD 599,367,030 23.7%
Bo Tan, MBA 116,849,920 4.61%
Dan Lou 62,001,010 2.45%
HSBC Global Asset Management (Hong Kong) Ltd. 51,949,854 2.05%
Bin Huang, MBA 33,919,350 1.34%
Dong Mei Su, PhD 26,403,630 1.04%
Allianz Global Investors Asia Pacific Ltd. 25,129,000 0.99%
The Vanguard Group, Inc. 23,848,500 0.94%
BlackRock Fund Advisors 21,726,000 0.86%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Biopharmaceuticals
Advertisement
Sector Biopharmaceuticals
1st jan.Capitalization (M$)
3SBIO INC. (ADR)0.00%2 876
CSL LIMITED3.38%37 825
ALEXION PHARMACEUTICAL..-37.06%26 923
GRIFOLS SA-9.50%13 411
3SBIO INC-18.52%2 876
JIANGXI BOYA BIO-PHARM..--.--%2 629
ABCAM PLC26.32%2 208
PROMETIC LIFE SCIENCES..-11.52%1 341
HUGEL INC--.--%1 316
ZHEJIANG WOLWO BIO-PHA..--.--%871
PHARMA MAR SA12.35%703
BIOTEST AG-6.98%675
VITAE PHARMACEUTICALS ..15.64%604
CHEMOCENTRYX INC-31.60%265
ARGOS THERAPEUTICS INC100.00%190
KAMADA LTD.19.20%187
MEDIWOUND LTD-6.44%175
VIVUS, INC.10.78%118
DICERNA PHARMACEUTICAL..-56.19%108
STRONGBRIDGE BIOPHARMA..-31.45%107
PEREGRINE PHARMACEUTIC..-63.56%103
Sector Biopharmaceuticals
3SBio Inc. (ADR) : Connections
Shanghai Aoxi Technology Information Consulting Co., Ltd.
Zhejiang Sunshine Pharmaceutical Co., Ltd.
Shenzhen Baishitong Technology Development Co., Ltd.
Hong Kong Sansheng Ltd.
Shenzhen Sciprogen Bio-Pharmaceutical Co., Ltd.
Taizhou Huan Sheng Investment Management Co., Ltd.
Collected Mind Ltd.
Ample Harvest Investments Ltd.
Liaoning Sunshine Science & Technology Development Co. Ltd.
CITIC Industrial Investment Group Corp. Ltd.
UTStarcom, Inc.
Mudanjiang Youbo Pharmaceutical Co., Ltd.
Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd.
Shenyang Sunshine Pharmaceutical Co. Ltd.
Liaoning Sunshine Bio-Pharmaceutical Co. Ltd.
Tocagen, Inc.
Zyngenia, Inc.
Beingmate Group Co. Ltd.
Excel Partner Holdings Ltd.
CFA Institute
The Multiple Myeloma Research Foundation, Inc.
Company contact information
3SBio, Inc.
Shenyang Economy & Tech Development
No. 3 A1, Road 10
Shenyang, Liaoning 110027

Phone : +86.24.25386000
Fax : +86.24.25811821
Web : www.3sbio.com
© 2016 People , Fundamentals and Ownership